ArticleTrials2023

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial.

Donglin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.